Interactive Effect of IGF2BP2 rs4402960 Variant, Smoking and Type 2 Diabetes

References

• Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol. 2012;8(4):228–236. doi:10.1038/nrendo.2011.183
   Web of Science ®Google Scholar
• Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
   PubMed Web of Science ®Google Scholar
• Li H-Y, Wu Y-L, Te Tu S, Hwu C-M, Liu J-S, Chuang L-M. Trends of mortality in diabetic patients in Taiwan: a nationwide survey in 2005–2014. J Formos Med Assoc. 2019;118:S83–S89. doi:10.1016/j.jfma.2019.07.008
   PubMedGoogle Scholar
• Chang C-J, Lu F-H, Yang Y-C, et al. Epidemiologic study of type 2 diabetes in Taiwan. Diabetes Res Clin Pract. 2000;50:S49–S59. doi:10.1016/S0168-8227(00)00179-0
   PubMed Web of Science ®Google Scholar
• Chen K-T, Chen C-J, Gregg EW, Engelgau MM, Narayan KV. Prevalence of type 2 diabetes mellitus in Taiwan: ethnic variation and risk factors. Diabetes Res Clin Pract. 2001;51(1):59–66. doi:10.1016/S0168-8227(00)00200-X
   PubMedGoogle Scholar
• Wannamethee SG, Shaper AG, Perry IJ. Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care. 2001;24(9):1590–1595. doi:10.2337/diacare.24.9.1590
   PubMedGoogle Scholar
• Wen C, Levy D, Cheng TY, Hsu C, Tsai S. Smoking behaviour in Taiwan, 2001. Tob Control. 2005;14(suppl1):i51–i55. doi:10.1136/tc.2004.008011
   PubMedGoogle Scholar
• Moffitt TE, Caspi A, Rutter M. Measured gene-environment interactions in psychopathology: concepts, research strategies, and implications for research, intervention, and public understanding of genetics. Perspect Psychol Sci. 2006;1(1):5–27. doi:10.1111/j.1745-6916.2006.00002.x
   PubMedGoogle Scholar
• Gillett M, Royle P, Snaith A, et al. Modifiable risk factors for type 2 diabetes mellitus. In: Non-Pharmacological Interventions to Reduce the Risk of Diabetes in People with Impaired Glucose Regulation: A Systematic Review and Economic Evaluation. NIHR Journals Library; 2012;16(33):15–26. doi:10.3310/hta16330
   Google Scholar
• Yeh H-C, Duncan BB, Schmidt MI, Wang N-Y, Brancati FL. Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann Intern Med. 2010;152(1):10–17. doi:10.7326/0003-4819-152-1-201001050-00005
   PubMed Web of Science ®Google Scholar
• Wu P, Rybin D, Bielak LF, et al. Smoking-by-genotype interaction in type 2 diabetes risk and fasting glucose. PLoS One. 2020;15(5):e0230815. doi:10.1371/journal.pone.0230815
   PubMedGoogle Scholar
• Yuan S, Larsson SC. A causal relationship between cigarette smoking and type 2 diabetes mellitus: a Mendelian randomization study. Sci Rep. 2019;9(1):1–4. doi:10.1038/s41598-019-56014-9
   PubMedGoogle Scholar
• Rao P, Wang H, Fang H, et al. Association between IGF2BP2 polymorphisms and type 2 diabetes mellitus: a case-control study and meta-analysis. Int J Environ Res Public Health. 2016;13(6):574. doi:10.3390/ijerph13060574
   PubMedGoogle Scholar
• Li Z, Gilbert JA, Zhang Y, et al. An HMGA2-IGF2BP2 axis regulates myoblast proliferation and myogenesis. Dev Cell. 2012;23(6):1176–1188. doi:10.1016/j.devcel.2012.10.019
   PubMed Web of Science ®Google Scholar
• Christiansen J, Kolte AM, Nielsen FC, Nielsen FC. IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes. J Mol Endocrinol. 2009;43(5):187–195. doi:10.1677/JME-09-0016
   PubMedGoogle Scholar
• Jia H, Yu L, Jiang Z, Ji Q. Association between IGF2BP2 rs4402960 polymorphism and risk of type 2 diabetes mellitus: a meta-analysis. Arch Med Res. 2011;42(5):361–367. doi:10.1016/j.arcmed.2011.08.001
   Google Scholar
• Zhang S-M, Xiao J-Z, Qian R, et al. Replication of association study between type 2 diabetes mellitus andIGF2BP2in Han Chinese population. Chin Med J. 2013;126(21):4013–4018.
   Google Scholar
• Wu -H-H, Liu N-J, Yang Z, et al. IGF2BP2 and obesity interaction analysis for type 2 diabetes mellitus in Chinese Han population. Eur J Med Res. 2014;19(1):40. doi:10.1186/2047-783X-19-40
   Google Scholar
• Biobank T. Taiwan Biobank. 2015.
   Google Scholar
• Fan C-T, Lin J-C, Lee C-H Taiwan Biobank: a project aiming to aid Taiwan’s transition into a biomedical island. 2008.
   Google Scholar
• Lin W-Y, Liu Y-L, Yang AC, Tsai S-J, Kuo P-H. Active cigarette smoking is associated with an exacerbation of genetic susceptibility to diabetes. Diabetes. 2020;69:2819–2829. doi:10.2337/db20-0156
   Web of Science ®Google Scholar
• Nfor ON, Wu M-F, Lee C-T, et al. Body mass index modulates the association between CDKAL1 rs10946398 variant and type 2 diabetes among Taiwanese women. Sci Rep. 2018;8(1):1–7. doi:10.1038/s41598-018-31415-4
   Google Scholar
• Maddatu J, Anderson-Baucum E, Evans-Molina C. Smoking and the risk of type 2 diabetes. Transl Res. 2017;184:101–107. doi:10.1016/j.trsl.2017.02.004
   PubMed Web of Science ®Google Scholar
• Huang Q, Yin J-Y, Dai X-P, et al. IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population. Acta Pharmacol Sin. 2010;31(6):709–717. doi:10.1038/aps.2010.47
   Google Scholar
• Luo W, Guo Z, Wu M, Hao C, Zhou Z, Yao X. Interaction of smoking and obesity on type 2 diabetes risk in a Chinese cohort. Physiol Behav. 2015;139:240–243. doi:10.1016/j.physbeh.2014.11.038
   Google Scholar
• Boo H-J, Min H-Y, Jang H-J, et al. The tobacco-specific carcinogen-operated calcium channel promotes lung tumorigenesis via IGF2 exocytosis in lung epithelial cells. Nat Commun. 2016;7(1):1–16. doi:10.1038/ncomms12961
   Google Scholar
• Groenewoud M, Dekker J, Fritsche A, et al. Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps. Diabetologia. 2008;51(9):1659–1663. doi:10.1007/s00125-008-1083-z
   Google Scholar